Durham’s restor3d raises $38M for launch of 3D orthopedic implants

Durham-based restor3d, a developer of three-dimensional printed implants for orthopedic use, has raised $38 million in venture capital. 

The funding was raised from existing and new private investors, including Summers Value Partners of Denver.

“This funding allows us to further scale our technology, expand access to truly personalized care, and continue setting new standards in orthopedic treatment,” said Kurt Jacobus, chief executive officer and co-founder of restor3d. “We are redefining what’s possible in orthopedics to better serve our surgeons and patients.”

The company said the funding was pivotal as it “accelerates the development and adoption of personalized orthopedic solutions at scale.”

Restor3d will use the capital to fund company growth and to launch four 3D-printed product lines in 2025 and 2026:

• Veritas Reverse Total Shoulder System, a single-tray instrument system making patient-specific implants accessible to a wider shoulder patient population. The system is pending 510(k) approval from the U.S. Food and Drug Administration.
• iTotal Identity 3DP Porous Cementless Total Knee, the first fully cementless, patient-specific knee system, is designed for optimal coverage and precise alignment while eliminating intraoperative guesswork. FDA 510(k) clearance was received in April.
• Kinos Modular Stem Total Ankle System, a total ankle system optimized for delivery through an anterior approach, providing enhanced surgical flexibility and personalized fit. FDA 510(k) clearance was received in late 2024.
• Velora 3DP Porous Acetabular System, a porous hip cup designed to promote osseointegration ─ the connection of living bone to a prosthetic device ─ in hip arthroplasty procedures. The product is pending FDA 510(k) approval.

“From the beginning, our mission at restor3d has been to transform orthopedic care through personalized, data-driven solutions,” Jacobus said. “By leveraging advanced 3D printing and AI-driven design, we are restoring mobility and improving lives ─ whether its helping patients return to work, get back on the golf course, or simply walk without pain. This approach has allowed us to expand market share efficiently, rapidly enter new segments, and drive strong year-over-year growth.”

The company said it was “rapidly” approaching positive operating cash flow, positioning it to continue reinvesting in innovation and expansion while maintaining financial stability.

restor3d holds proprietary expertise and intellectual property in 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless, data-backed care to optimize individual patient outcomes.